In a minority of relapsed myeloma, patient's disease may spread into extramedullary sites, associated with high degrees of heterogeneity. The breadth of myeloma therapeutic armamentarium allows clinicians to manage its heterogeneous presentation, including intracranial relapses, with fair success resulting in a significant prolongation of survival.

A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?

Markovic U.;Calafiore V.;Martino E.;Giubbolini R.;Parisi M. S.;Romano A.;Di Raimondo F.
;
2019-01-01

Abstract

In a minority of relapsed myeloma, patient's disease may spread into extramedullary sites, associated with high degrees of heterogeneity. The breadth of myeloma therapeutic armamentarium allows clinicians to manage its heterogeneous presentation, including intracranial relapses, with fair success resulting in a significant prolongation of survival.
2019
bortezomib; extramedullary disease; multiple myeloma; refractoriness
File in questo prodotto:
File Dimensione Formato  
rare case of multiple myeloma with intracranial extramedullary relapse.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Dimensione 761.01 kB
Formato Adobe PDF
761.01 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/493724
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact